Physical behavior of KR-12 peptide on solid surfaces and Langmuir-Blodgett lipid films: Complementary approaches to its antimicrobial mode against S. aureus.


Journal

Biochimica et biophysica acta. Biomembranes
ISSN: 1879-2642
Titre abrégé: Biochim Biophys Acta Biomembr
Pays: Netherlands
ID NLM: 101731713

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 04 05 2021
revised: 13 08 2021
accepted: 13 09 2021
pubmed: 25 9 2021
medline: 29 12 2021
entrez: 24 9 2021
Statut: ppublish

Résumé

Biophysical characterization of antimicrobial peptides helps to understand the mechanistic aspects of their action. The physical behavior of the KR-12 antimicrobial peptide (e.g. orientation and changes in secondary structure), was analyzed after interactions with a Staphylococcus aureus membrane model and solid surfaces. We performed antimicrobial tests using Gram-positive S. aureus (ATCC 25923) bacteria. Moreover, Langmuir-Blodgett experiments showed that the synthetic peptide can disturb the lipidic membrane at a concentration lower than the Minimum Inhibitory Concentration, thus confirming that KR-12/lipid interactions are involved. Partially- and fully-deactivated KR-12 hybrid samples were obtained by physisorption and covalent immobilization in chitosan/silica and glyoxal-rich solid supports. The correlation of Langmuir-Blodgett data with the α-helix formation, followed by FTIR-ATR in a frozen-like state, and the antimicrobial activity showed the importance of these interactions and conformation changes on the first step action mode of this peptide. This is the first time that material science (immobilization in solid surfaces assisted by FTIR-ATR analysis in frozen-like state) and physical (Langmuir-Blodgett/Schaefer) approaches are combined for exploring mechanistic aspects of the primary action mode of the KR-12 antimicrobial peptide against S. aureus.

Identifiants

pubmed: 34560046
pii: S0005-2736(21)00227-3
doi: 10.1016/j.bbamem.2021.183779
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Peptides 0
Cathelicidins 0
Lipids 0
Membrane Lipids 0
Peptide Fragments 0
cathelicidin LL-37 (18-29), human 0
Chitosan 9012-76-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

183779

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Katerine Chanci (K)

Biophysics Group, Institute of Physics, University of Antioquia, Colombia.

Johnatan Diosa (J)

Materials Science Group, University of Antioquia, Colombia.

Marco A Giraldo (MA)

Biophysics Group, Institute of Physics, University of Antioquia, Colombia.

Monica Mesa (M)

Materials Science Group, Institute of Chemistry, University of Antioquia, Calle 70 #52-21, AA 1226 Medellín, Colombia. Electronic address: monica.mesa@udea.edu.co.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH